Understanding Heterogeneous Drug Procurement Behaviour of Healthcare Institutions Under Pooled Procurement: Evidence From China
International Journal of Health Policy and Management · 07.06.2026 · 15 · 9372
DOI: 10.34172/ijhpm.9372 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Policy and Management, online erschienen am 07.06.2026. Verfasst von Boya Zhao und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
While the overall impact of pooled drug procurement on drug procurement has been evaluated, little is known about how healthcare institutions’ pre-policy procurement composition is associated with heterogeneous post-policy procurement responses. This study addresses this gap under China’s National Volume-Based Procurement (NVBP) policy.
Methods
We used monthly procurement data from January 2018 to December 2020 from four provinces in China, covering both pre- and post-policy periods, as the NVBP policy was implemented in January 2020. Outcomes were procurement volumes, measured as the number of defined daily doses (DDDs), of NVBP-covered drugs (bid-winning and non-winning products) and their clinically substitutable alternatives. All healthcare institutions in the selected provinces were included and stratified by (1) their pre-policy share of bid-winning products among NVBP drugs and (2) their pre-policy share of NVBP drugs among both NVBP and alternative drugs, to assess institutional heterogeneity. Interrupted time series (ITS) analysis was conducted to assess the immediate (level) and long-term (slope) post-policy changes.
Results
Procurement volumes of bid-winning products increased substantially following the policy (level change: 1275%, P
Zitieren
APA
Zhao, B., Cheng, Z., & Feng, X. L. (2026). Understanding Heterogeneous Drug Procurement Behaviour of Healthcare Institutions Under Pooled Procurement: Evidence From China. International Journal of Health Policy and Management, 15, 9372. https://doi.org/10.34172/ijhpm.9372
Vancouver
Zhao B, Cheng Z, Feng XL. Understanding Heterogeneous Drug Procurement Behaviour of Healthcare Institutions Under Pooled Procurement: Evidence From China. International Journal of Health Policy and Management. 2026;15:9372. doi:10.34172/ijhpm.9372
BibTeX
@article{Zhao2026,
author = {Zhao, Boya and Cheng, Zhao and Feng, Xing Lin},
title = {Understanding Heterogeneous Drug Procurement Behaviour of Healthcare Institutions Under Pooled Procurement: Evidence From China},
journal = {International Journal of Health Policy and Management},
year = {2026},
volume = {15},
pages = {9372},
doi = {10.34172/ijhpm.9372}
}
EUVIMED